Olivier Menage

CEO/Marketing/Strategy

Olivier Menage
Lasne, Belgien

Erfahrungen

Jan. 2022 - Bis heute
2 Jahren 3 Monaten

Co-founder and CEO

PEYEONEER MEDTECH

  • Co-founded and steered a pioneering healthcare startup in collaboration with Maastricht University. Defined and executed the company's vision, focusing on innovative glaucoma treatment implants.
  • Conducted extensive market research to understand competitive landscapes and consumer needs. Developed a comprehensive strategy for product positioning and market entry, particularly targeting the US market.
  • Led the development of market access and regulatory strategies, adapting to the dynamic healthcare environment. Spearheaded preparations for initial clinical trials in the United States.
  • Successfully negotiated with tech transfer offices, ensuring the protection and commercial viability of product innovations.
Jan. 2022 - Dez. 2023
1 Jahr

VP Marketing International

WALLABY PHENOX

  • Championed the development and execution of international marketing strategies, leading to the successful launch of products across 60 countries. Ensured longevity and market relevance through strategic planning.
  • Played a critical role in comprehensive market research initiatives, contributing to the seamless integration of Phenox and Wallaby into the Medtech Europe Neurovascular Tracker.
  • Led a significant rebranding initiative for WallabyPhenox, receiving unanimous board approval. This initiative played a key role in strengthening the brand's position in the market.
  • Worked closely with Clinical Affairs and Market Access teams to refine clinical claims and develop effective reimbursement strategies, enhancing product credibility and adoption.
Jan. 2020 - Bis heute
5 Jahren 3 Monaten

Co-founder and CEO

MONA.health

  • Established an innovative healthcare startup, focusing on the application of artificial intelligence for large-scale eye disease screening. This venture, in partnership with VITO and KU Leuven, positioned MONA.health as a leader in digital health innovation.
  • Directed the development of AI-driven solutions targeting diabetic retinopathy. Successfully navigated the regulatory landscape to secure CE mark approval, demonstrating compliance with European health and safety standards.
  • Successfully raised €1.5 million in seed funding and secured an additional €250k in non-dilutive financing, underlining the project's viability and potential for growth.
  • Assembled and led a dedicated team of professionals, focusing on expanding the startup's reach across Europe. Developed strategies for market penetration and customer engagement.
  • Forged strategic partnerships for commercialization and research. Notably collaborated with Fujitsu in the UK, enhancing the company's research capabilities and market presence.
Jan. 2016 - Dez. 2020
3 Jahren

Marketing Director EMEA

ABBOTT

Market leader in coronary and peripheral artery disease, EMEA sales $1bn

  • Led a dynamic team of 18, overseeing product marketing, communications, and training initiatives.
  • Orchestrated the successful repositioning and launch of Xience Sierra, achieving significant market share growth. 136% above expectations, 3% market share increase (28% to 31% in 6 months)
  • Formulated therapy development strategies, resulting in a 30% annual revenue surge.
  • Exceeding plan by $12m
  • Modernized communication channel mix with video and targeted digital content
Jan. 2015 - Dez. 2017
3 Jahren

Marketing Director Minimally Invasive Surgery Expansion EMEA

MEDTRONIC

Global leader in surgical devices, $2 billion EMEA sales

  • Drove the adoption of minimally invasive surgery techniques in EMEA, achieving a 20% increase in adoption rates over 5 years.
  • innovative solutions and new educational programs
  • Pioneered strategies to transition from a device-centric approach to a holistic solutions provider.
  • Developed innovative business models to establish centers of excellence for minimally invasive surgery.
Jan. 2010 - Dez. 2015
5 Jahren

Director Procedural Marketing Bariatric Surgery EMEA

COVIDIEN

  • Transformed a traditional transactional go-to-market model into a solution selling model.
  • Developed and implemented a new business model based on innovative consulting services to obesity centers, driving $12M in incremental annual growth.
  • Managed a team of 17 obesity specialists in Europe
  • Winner of the 2014 Covidien Innovation Award, Business Model
  • Designed and implemented e-health platform with connected device to improve patient journey beforehand after surgery
  • Developed partnerships with patient organizations across Europe
  • Re-launched European Obesity Day through a pan-European PR campaign with KOLs and patients
Jan. 2009 - Dez. 2011
3 Jahren

Marketing Director Energy Based Device EMEA

COVIDIEN

  • Developed thoracic surgery market in Europe, launched LigaSure for lobectomy
  • Pursue regulatory process to obtain CE Mark for thoracic indication
  • Conducted the Ligasure 2 clinical study, a controlled, randomized, multi-center Phase 3 study in France comparing LigaSure to stapling in lobectomy.
Jan. 2007 - Dez. 2009
2 Jahren

Head of Healthcare Policies and Payments Europe

ACCURAY

  • Managed the establishment of DRGs in France, Switzerland, Germany and Italy
  • Developed and implemented strategies to accelerate reimbursement for CyberKnife procedures through partnerships with clinicians and national healthcare payers
Jan. 2002 - Dez. 2008
6 Jahren

Senior Customer Programs Manager Cardiology International

BOSTON SCIENTIFIC

  • Designed and implemented the first interventional cardiology registry with clinical monitoring for the launch of the TAXUS stent: Milestone I and II (6192 patients, 164 sites, 31 countries).
  • Led the strategic development of international advisory boards
  • Partnered with the European Society of Cardiology (ESC) to include the TAXUS stent in new guidelines
Jan. 1999 - Dez. 2003
3 Jahren

Pricing Manager Cardiology and Endosurgery Europe

BOSTON SCIENTIFIC

Led the pricing strategy for the European launch of the TAXUS Drug Eluting Stent, resulting in a 60% market share 6 months after launch.

Jan. 1997 - Dez. 1999
3 Jahren

Financial Controller France

LIFESCAN

  • Led financial planning and analysis and managed customer service.
  • Initiated and led a major re-engineering of the pricing structure to comply with French regulatory requirements following an antitrust investigation.
Jan. 1993 - Dez. 1997
3 Jahren

Financial and Operations Analyst

JOHNSON & JOHNSON CONSUMER

Manages the distributors for J&J consumer in 25 countries

  • Orchestrated the management of distributors across 25 countries, ensuring seamless operations and optimal distribution strategies.
  • Spearheaded logistics coordination among 20 different plants worldwide, conducting comprehensive sourcing analyses that culminated in the strategic recommendation of Athens as the global distribution center.
  • Led a European task force comprising 10 members, successfully consolidating the production of lip care sticks from five sites to one, resulting in annual cost savings of $1.2 million.
  • Innovatively designed and implemented a risk policy for credit management, effectively reducing overdue payments by 20%, equivalent to a value of $5 million.

Zusammenfassung

Seasoned Healthcare Executive with over 25 years of global leadership in healthcare management and innovation, aiming to lead the Medical Business Unit at Materialise. Bringing a strong background in strategic planning, commercialization of medical devices, and team development to drive long-term strategic goals and market growth. - Strategic Leadership in Healthcare - Commercialization of Medical Devices in US and EU - Cross-Functional Team Management and Coaching - Financial Planning and Budget Management - Market Analysis and Growth Opportunity Identification - Product and Service Evolution Knowledge - Strong Interpersonal and Stakeholder Relationship Skills - Proactive and Entrepreneurial Mindset

Sprachen

Französisch
Muttersprache
Englisch
Verhandlungssicher

Ausbildung

Okt. 1987 - Juni 1994

University of Angers

Doctor of Pharmacy, Thesis on Drug eluting stents and thrombosis, graduated with honours · Doctor of Pharmacy · Angers, Frankreich

Zertifikate & Bescheinigungen

CE Mark

CE Mark

Ähnliche Freelancer

Entdecken Sie andere Experten mit ähnlichen Qualifikationen und Erfahrungen.

Verifizierter Experte
Michal Konstacky

Managing Director

Profil ansehen
Verifizierter Experte
Steffen Eschinger

Senior Project Manager

Profil ansehen
Verifizierter Experte
Ulrich Eggert

Interim Manager / Geschäftsführer / Sales Director / Marketing Director

Profil ansehen
Verifizierter Experte
Sandy Glueckstein

Change & Transformation Management & New Work

Profil ansehen
Verifizierter Experte
Pieter Geeraerts

Customer & Sales Oriented CxO

Profil ansehen
Verifizierter Experte
Oliver Schulz

Diplom-Ingenieur Und Diplom-Betriebswirt, Unabhängiger Berater Und Projektmanager Für Organisationsentwicklung, Change-Managemen

Profil ansehen
Verifizierter Experte
Bruno Pirovino-Zürcher

Executive Director Finance / Board Member

Profil ansehen
Verifizierter Experte
Patrick Roose

Interim manager for digital transformation, company restructuring & optimisation

Profil ansehen
Verifizierter Experte
Klaus Schmitt

IT Project Leader and Senior Consultant

Profil ansehen
Verifizierter Experte
Philip Scheibl

Interim & Consulting - I solve problems and make cool things work digital | worldwide | critical & original

Profil ansehen
Verifizierter Experte
Mark Grabfelder

Project Lead for Care Home Support Processes

Profil ansehen
Verifizierter Experte
Vibhuti Singh

AI Products | Strategy, Go-to-market, Global Growth | Saas, AI/ML, DeepTech

Profil ansehen
Verifizierter Experte
Michael Hoffmann

Digital Transformation Manager

Profil ansehen
Verifizierter Experte
Grossmann Florian

Director/Senior Projekt Manager

Profil ansehen
Verifizierter Experte
Patrick Schmidt

Transformative Commercial & Customer Strategy

Profil ansehen